Jeff Garro
Stock Analyst at Stephens & Co.
(0.49)
# 3,024
Out of 4,479 analysts
39
Total ratings
13.33%
Success rate
-19.38%
Average return
Main Sectors:
13 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PHR Phreesia | Reiterates: Overweight | $28 | $20.50 | +36.59% | 8 | May 31, 2024 | |
| MDRX Veradigm | Reiterates: Equal-Weight | $13 | $9.66 | +34.58% | 6 | Nov 14, 2023 | |
| CERT Certara | Reiterates: Overweight | $20 | $13.66 | +46.41% | 4 | Oct 11, 2023 | |
| ACCD Accolade | Reiterates: Overweight | $18 | $3.53 | +409.92% | 5 | Oct 5, 2023 | |
| TDOC Teladoc Health | Reiterates: Equal-Weight | $28 | $9.40 | +197.87% | 2 | Jul 26, 2023 | |
| EVH Evolent Health | Reiterates: Overweight | $40 | $19.25 | +107.79% | 2 | May 4, 2023 | |
| RCM R1 RCM | Initiates: Overweight | $18 | $10.90 | +65.14% | 1 | Apr 12, 2023 | |
| PRVA Privia Health Group | Initiates: Overweight | $33 | $17.16 | +92.31% | 1 | Apr 12, 2023 | |
| OPRX OptimizeRx | Maintains: Neutral | $29 → $16 | $10.07 | +58.89% | 2 | Aug 10, 2022 | |
| ALHC Alignment Healthcare | Maintains: Overweight | $15 → $20 | $7.88 | +153.81% | 3 | Aug 5, 2022 | |
| INNV InnovAge Holding | Maintains: Underweight | $5 → $3.9 | $5.03 | -22.47% | 2 | May 11, 2022 | |
| SLQT SelectQuote | Maintains: Neutral | $4 → $3 | $3.15 | -4.76% | 2 | May 6, 2022 | |
| IQV IQVIA Holdings | Upgrades: Overweight | $231 → $255 | $207.47 | +22.91% | 1 | Apr 29, 2022 |
Phreesia
May 31, 2024
Reiterates: Overweight
Price Target: $28
Current: $20.50
Upside: +36.59%
Veradigm
Nov 14, 2023
Reiterates: Equal-Weight
Price Target: $13
Current: $9.66
Upside: +34.58%
Certara
Oct 11, 2023
Reiterates: Overweight
Price Target: $20
Current: $13.66
Upside: +46.41%
Accolade
Oct 5, 2023
Reiterates: Overweight
Price Target: $18
Current: $3.53
Upside: +409.92%
Teladoc Health
Jul 26, 2023
Reiterates: Equal-Weight
Price Target: $28
Current: $9.40
Upside: +197.87%
Evolent Health
May 4, 2023
Reiterates: Overweight
Price Target: $40
Current: $19.25
Upside: +107.79%
R1 RCM
Apr 12, 2023
Initiates: Overweight
Price Target: $18
Current: $10.90
Upside: +65.14%
Privia Health Group
Apr 12, 2023
Initiates: Overweight
Price Target: $33
Current: $17.16
Upside: +92.31%
OptimizeRx
Aug 10, 2022
Maintains: Neutral
Price Target: $29 → $16
Current: $10.07
Upside: +58.89%
Alignment Healthcare
Aug 5, 2022
Maintains: Overweight
Price Target: $15 → $20
Current: $7.88
Upside: +153.81%
InnovAge Holding
May 11, 2022
Maintains: Underweight
Price Target: $5 → $3.9
Current: $5.03
Upside: -22.47%
SelectQuote
May 6, 2022
Maintains: Neutral
Price Target: $4 → $3
Current: $3.15
Upside: -4.76%
IQVIA Holdings
Apr 29, 2022
Upgrades: Overweight
Price Target: $231 → $255
Current: $207.47
Upside: +22.91%